A
Anebulo Pharmaceuticals, Inc. (ANEB)
PNK – Real vaqt narxi. Valyuta: USD
0.52
+0.06 (13.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
PNK – Real vaqt narxi. Valyuta: USD
0.52
+0.06 (13.04%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Anebulo Pharmaceuticals, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda beixtiyor marixuana zaharlanishi, o'tkir kannabinoid intoksikatsiyasi va o'tkir marixuana ta'siridan kelib chiqqan holatlarni davolash usullarini ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi selonabant, kannabinoid bog'lovchi retseptor tip-1 (CB1) ning kichik molekulali antagonistidir, u marixuana toksikligiga qarshi maxsus antidotga bo'lgan tibbiy ehtiyojni qondirish uchun II fazali klinik sinovdan o'tmoqda. Anebulo Pharmaceuticals, Inc. 2020 yilda tashkil etilgan va Lakeway, Texas shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Joseph F. Lawler M.D., Ph.D. | Founder & Chairman |
| Dr. Kenneth C. Cundy Ph.D. | Chief Scientific Officer |
| Mr. Daniel V. George | Acting CFO & Secretary |
| Mr. Richard Anthony Cunningham | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-02 | 15-12G | form15-12g.htm |
| 2026-02-17 | 25 | form25.htm |
| 2026-02-12 | 10-Q | form10-q.htm |
| 2026-02-06 | 8-K | form8-k.htm |
| 2026-01-29 | SC TO-I/A | formsctoia.htm |
| 2026-01-27 | SC TO-I/A | formsctoia.htm |
| 2026-01-08 | SC TO-I/A | formsc-toia.htm |
| 2025-12-22 | SC TO-I | formsc-toi.htm |
| 2025-12-22 | 8-K | form8-k.htm |
| 2025-11-13 | 10-Q | form10-q.htm |